Paroxetine Prevents Loss of Nigrostriatal Dopaminergic Neurons by Inhibiting Brain Inflammation and Oxidative Stress in an Experimental Model of Parkinson’s Disease-Reference-Cited by-同舟云学术

Paroxetine Prevents Loss of Nigrostriatal Dopaminergic Neurons by Inhibiting Brain Inflammation and Oxidative Stress in an Experimental Model of Parkinson’s Disease

Published:2010-06-21 Issue:2 Volume:185 Page:1230-1237
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Chung Young C.,Kim Sang R.,Jin Byung K.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference53 articles.

1. Parkinson's Disease

2. ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE

3. Diagnosis and treatment of Parkinson disease: molecules to medicine

4. Neuroinflammation in Parkinson's disease: a target for neuroprotection?

5. Ablation of the Inflammatory Enzyme Myeloperoxidase Mitigates Features of Parkinson's Disease in Mice

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escitalopram moderately outperforms citalopram towards anti-neuroinflammation and neuroprotection in 6-hydroxydopamine-induced mouse model of Parkinson’s disease;International Immunopharmacology;2024-09

2. Crif1 deficiency in dopamine neurons triggers early-onset parkinsonism;Molecular Psychiatry;2023-08-30

3. Ninjinyoeito Prevents Onset of Depression-Like Behavior and Reduces Hippocampal iNOS Expression in Senescence-Accelerated Mouse Prone 8 Mice;Evidence-Based Complementary and Alternative Medicine;2023-08-09

4. Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats;International Journal of Neuropsychopharmacology;2022-11-26

5. Thiocyanate Reduces Motor Impairment in the hMPO-A53T PD Mouse Model While Reducing MPO-Oxidation of Alpha Synuclein in Enlarged LYVE1/AQP4 Positive Periventricular Glymphatic Vessels;Antioxidants;2022-11-26